あすか製薬ホールディングス(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4886/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2023/03/03 | 日証協 | 221,952株 | +3.46% | 69,676株 | +82.21% | 249,950株 | +5.14% | 17,124株 | +14.29% |
2023/02/24 | 日証協 | 214,528株 | +0.7% | 38,239株 | +69.56% | 237,726株 | -0.42% | 14,983株 | -22.63% |
2023/02/17 | 日証協 | 213,028株 | -1.02% | 22,552株 | +61.79% | 238,726株 | -1.07% | 19,366株 | -42.36% |
2023/02/10 | 日証協 | 215,215株 | +2.87% | 13,939株 | -29.24% | 241,313株 | -0.79% | 33,600株 | +10.26% |
2023/02/03 | 日証協 | 209,215株 | +0.55% | 19,700株 | +2323.12% | 243,227株 | +0.04% | 30,474株 | +271.45% |
2023/01/27 | 日証協 | 208,065株 | -0.23% | 813株 | -13.97% | 243,140株 | -3.49% | 8,204株 | +2.88% |
2023/01/20 | 日証協 | 208,552株 | -3.41% | 945株 | -34.65% | 251,927株 | -1.45% | 7,974株 | -70.22% |
2023/01/13 | 日証協 | 215,921株 | -5.83% | 1,446株 | -80.29% | 255,640株 | +3.91% | 26,778株 | +9.51% |
2023/01/06 | 日証協 | 229,283株 | +0.71% | 7,338株 | -94.96% | 246,016株 | +2.12% | 24,453株 | +94.33% |
2022/12/30 | 日証協 | 227,676株 | +145.93% | 145,726株 | +230.9% | 240,916株 | -0.66% | 12,583株 | -89.53% |
2022/12/23 | 日証協 | 92,576株 | -35.9% | 44,039株 | +197.06% | 242,516株 | +5.21% | 120,166株 | +650.38% |
2022/12/16 | 日証協 | 144,428株 | -3.86% | 14,825株 | -4.43% | 230,516株 | -0.82% | 16,014株 | -41.09% |
2022/12/09 | 日証協 | 150,228株 | +2.21% | 15,513株 | -56.56% | 232,432株 | +3.56% | 27,183株 | +13.82% |
2022/12/02 | 日証協 | 146,978株 | -11.95% | 35,713株 | -44.03% | 224,449株 | +0.91% | 23,883株 | +10.56% |
2022/11/18 | 日証協 | 128,828株 | +5.01% | 43,087株 | -2.61% | 215,331株 | +1.65% | 13,383株 | +21.85% |
2022/11/11 | 日証協 | 122,677株 | -1.57% | 44,242株 | -24.26% | 211,839株 | -0.47% | 10,983株 | -58.68% |
2022/11/04 | 日証協 | 124,628株 | +10.7% | 58,410株 | +58.61% | 212,840株 | +7.63% | 26,583株 | +121.84% |
2022/10/28 | 日証協 | 112,577株 | -5.46% | 36,826株 | +8.22% | 197,757株 | -3.93% | 11,983株 | +49.79% |
2022/10/21 | 日証協 | 119,077株 | -6% | 34,029株 | -64.11% | 205,851株 | -3.02% | 8,000株 | -34.89% |
※株式分割は考慮していませんのでご注意ください。
Page Top